Field Trial on Efficacy of Supervised Monthly Dose of 600 mg Rifampin, 400 mg Ofloxacin and 100 mg Minocycline for the Treatment of Leprosy; First Results

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 65, Issue 2, 1997, Pages 224-229

  Mane, Ibrahima ^a   Cartel, Jean Louis ^a   Grosset, Jacques Henri ^b  

^a Institut de Leprologie Appliquee Dakar   (Senegal)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE; OFLOXACIN; RIFAMPICIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; FEMALE; HUMAN; INFECTION CONTROL; LEPROSY; MAJOR CLINICAL STUDY; MALE; SENEGAL; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MALE; MIDDLE AGED; MINOCYCLINE; OFLOXACIN; RIFAMPIN;

EID: 0030863306     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. BIRCH, M. C. Leprosy treatment in Nepal with multidrug regimens. Lepr. Rev. 55 (1984) 255-264.
2. GELBER, R. H., Siu, P. and TSANG, N. Clarithromycin at very low level and on intermittent administration inhibits the growth of M. leprae in mice. Int. J. Lepr. 60 (1992) 485-487.
3. GROSSET, J.-H. Traitement antibactérien de la lèpre. In: La Lèpre. Sansarricq, H., Coord. Paris: Ellipses, 1995.
4. GROSSET, J.-H., GUELPA-LAURAS, C. C., PERANI, E.G. and BEOLETTO, C. Activity of oftoxacin against Mvcobacterium leprae in the mouse. Int. J. Lepr. 56 (1988) 259-264.
5. JI, B., JAMET, P., PERANI, E., BOBIN, P. and GROSSET, J.-H. Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy. J. Infect. Dis. 168 (1993) 188-190.
6. JI, B., PERANI, E. G. and GROSSET, J.-H. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice. Int. J. Lepr. 60 (1992) 485-487.
7. JI, B., PERANI, E. G., PETINON, C. and GROSSET, J.-H. Bactericidal activities of combination of new drugs against Mycobacterium leprae in nude mice. Antimicrob. Agents Chemother. 40 (1996) 393-399.
8. RIDLEY, D. S. Bacterial indices. In: Leprosy in Theory and Practice. Cochrane, R. G. and Davey, T. F., eds. Baltimore: Williams and Wilkins, 1964, pp. 620-622.
9. ROSE, P. Short-course multidrug therapy for paucibacillary patients in Guyana: preliminary communication. Lepr. Rev. 55 (1984) 134-147.
10. SAMUEL, N. M., SAMUEL, S., NAKAMI, N. and MURNU, R. Multidrug treatment of leprosy - practical application in Nepal. Lepr. Rev. 55 (1984) 265-272.
11. WHO ACTION PROGRAMME FOR THE ELIMINATION OF LEPROSY. A guide for the elimination of leprosy as a public health problem. Geneva: World Health Organization, 1995.
12. WHO LEPROSY UNIT. Risk of relapse in leprosy. Geneva: World Health Organization 1994. WHO/CTD/LEP.94.1.
13. WHO STUDY GROUP. Chemotherapy of leprosy for control programmes. Geneva: World Health Organization, 1982. Tech. Rep. Ser. 675.
14. WHO STUDY GROUP. Chemotherapy of leprosy. Geneva: World Health Organization, 1994. Tech. Rep. Ser. 746.
15. XIONG, J-H., JI, B., PERONI, E. and GROSSETT, J.-H. Further study on the effectiveness of single doses of clarythromicin and minocycline against Mycobacterium leprae in mice. Int. J. Lepr. 62 (1994) 37-42.